France Celiac Disease Treatment Market

France Celiac Disease Treatment Market Insights Forecasts to 2035

• The France Celiac Disease Treatment Market Size Was Estimated at USD 30.6 Million in 2024
• The France Celiac Disease Treatment Market Size is Expected to Grow at a CAGR of Around 11.10% from 2025 to 2035
• The France Celiac Disease Treatment Market Size is Expected to Reach USD 97.4 Million by 2035

 

According to a research report published by Decision Advisor & Consulting, The France Celiac Disease Treatment Market Size is Anticipated to reach USD 97.4 Million by 2035, Growing at a CAGR of 11.10% from 2025 to 2035. The France celiac disease treatment market is driven by rising awareness and diagnosis, increasing demand for gluten?free diets and supplements, improved diagnostic technologies, supportive food labeling regulations, and growing health-conscious eating trends.

 

Market Overview

The France celiac disease treatment market is the healthcare and consumer product sector that deals with the management and treatment of celiac disease, which is an autoimmune disorder activated by the consumption of gluten. It comprises gluten-free foods, dietary supplements, enzyme therapies, and medical care services that help in symptom relief, complication prevention, and quality of life enhancement for the patients. Besides, the market also includes diagnostic devices and patient education programs that facilitate early diagnosis and continuous management of the disease in France.

 

Celiac disease is estimated to affect around 1% of the population in France, which corresponds to about 650,000-700,000 people. However, only 10-20% of them are officially diagnosed because of under recognition and the presence of nonspecific symptoms. Such a large population of undiagnosed patients represents a major medical need that is not being met. Treatment is mostly based on a strict, lifelong gluten-free diet with nutritional support to prevent deficiencies and complications. Increased awareness among medical professionals and consumers, as well as better diagnostic tools, are raising the number of diagnosed cases. Thus, treatment options and specialized dietary products are becoming more and more important in the country.

 

The France celiac disease treatment market might see growth due to an increasing interest in gluten-free foods and supplements, also among non-celiac people who want to eat healthier. The partial reimbursement of gluten-free products (60%) for diagnosed patients through national health insurance lowers the cost of treatment, thus encouraging the adoption. For example, AFDIAG educates patients and supports research, whereas public, government programs are concerned with enhancing diagnosis, treatment guidelines, and awareness. Besides these, there is an increasing focus on nutrition and wellness, which together pose a great market potential for manufacturers, healthcare providers, and innovators of dietary products in France.

 

Report Coverage

This research report categorizes the market for the France celiac disease treatment market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France celiac disease treatment market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France celiac disease treatment market.

 

Driving Factors

The France celiac disease treatment market has several factors responsible for its growth. The most prominent ones include awareness and diagnosis, the rising number of cases, consumption of gluten-free foods and supplements, health-conscious dietary trends, partial government reimbursement (60%), and advancements in diagnostic and supportive therapies.

 

Restraining Factors

The France celiac disease treatment market is restrained due to a limited number of treatment options available besides a rigorous gluten-free diet, the expensive nature of gluten-free products, underdiagnosis of the disease, low patient compliance with dietary restrictions, and the absence of extensive government-funded therapeutic interventions.

 

Market Segmentation

The France celiac disease treatment market share is classified into treatment and distribution channel.

• The vitamins & minerals segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France celiac disease treatment market is segmented by treatment into vitamins & minerals, gluten-degrading enzymes, symptomatic treatment, and others. Among these, the vitamins & minerals segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The vitamins & minerals segment is growing because celiac disease causes nutrient deficiencies, driving demand for supplements like iron, calcium, and vitamin D, supported by increased awareness, fortified gluten-free foods, and adherence to lifelong dietary management.

 

• The retail pharmacies segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The France celiac disease treatment market is segmented by distribution channel into hospital pharmacies and retail pharmacies. Among these, the retail pharmacies segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The retail pharmacies’ segmental growth is due to wider accessibility of gluten-free supplements and vitamins, convenience for patients purchasing over-the-counter products, increasing consumer awareness of celiac disease, and the rising demand for health and nutrition products outside hospital settings.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France celiac disease treatment market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• General Mills, Inc.
• Kraft Heinz Company
• Dr. Schär AG
• The Hain Celestial Group, Inc.
• Conagra Brands, Inc.
• Barilla Group
• Hero Group
• Bob’s Red Mill Natural Foods, Inc.
• Boulder Brands
• Amneal Pharmaceuticals
• Hikma Pharmaceuticals PLC
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the France celiac disease treatment market based on the below-mentioned segments:

 

France Celiac Disease Treatment Market, By Treatment

• Vitamins & Minerals
• Gluten-Degrading Enzymes
• Symptomatic Treatment
• Others

 

France Celiac Disease Treatment Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies

 

FAQ’s

1. What is the France celiac disease treatment market size in 2024?

The France celiac disease treatment market size was estimated at USD 30.6 million in 2024.

 

2. What is the projected market size of the France celiac disease treatment market by 2035?

The France celiac disease treatment market size is expected to reach USD 97.4 million by 2035.

 

3. What is the CAGR of the France celiac disease treatment market?

The France celiac disease treatment market size is expected to grow at a CAGR of around 11.10% from 2024 to 2035.

 

4. What are the key growth drivers of the France celiac disease treatment market?

The France celiac disease treatment market is driven by rising awareness and diagnosis, increasing demand for gluten?free diets and supplements, improved diagnostic technologies, supportive food labeling regulations, and growing health-conscious eating trends.

 

5. Which distribution channel segment dominated the market in 2024?

The retail pharmacies segment dominated the market in 2024.

 

6. What segments are covered in the France celiac disease treatment market report?

The France celiac disease treatment market is segmented on the basis of treatment and distribution channel.

 

7. Who are the key players in the France celiac disease treatment market?

Key companies include General Mills, Inc., Kraft Heinz Company, Nestle S.A., Dr. Schar AG, The Hain Celestial Group, Inc., Conagra Brands, Inc., Barilla Group, Hero Group, Bob’s Red Mill Natural Foods, Inc., Boulder Brands, Amneal Pharmaceuticals, Hikma Pharmaceuticals PLC, and others.

 

8. Who are the target audiences for this market report?

The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).